Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: GW readies wonder weed drug

The Telegraph

Friday 20 Jun 2003

---
GW Pharmaceuticals, which is developing cannabis-based medicines, yesterday
said that its first product, Sativex, should be available for prescription
in the UK by the end of 2003.

Geoffrey Guy, the executive chairman, said that the company would not be
concerned if regulatory approval slips into the first quarter of 2004.

The company yesterday announced six-month results in line with
expectations, with its pre-tax loss widening to UKP7.3m from UKP5.7m last
year. GW shares fell 7 to 230.5p yesterday. GW will book a UKP5m fee from
Bayer, its marketing partner for Sativex.

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!